Stephen P. Newman

7.7k total citations
101 papers, 5.9k citations indexed

About

Stephen P. Newman is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Biomedical Engineering. According to data from OpenAlex, Stephen P. Newman has authored 101 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 46 papers in Physiology and 8 papers in Biomedical Engineering. Recurrent topics in Stephen P. Newman's work include Inhalation and Respiratory Drug Delivery (89 papers), Asthma and respiratory diseases (46 papers) and Respiratory and Cough-Related Research (24 papers). Stephen P. Newman is often cited by papers focused on Inhalation and Respiratory Drug Delivery (89 papers), Asthma and respiratory diseases (46 papers) and Respiratory and Cough-Related Research (24 papers). Stephen P. Newman collaborates with scholars based in United Kingdom, United States and Australia. Stephen P. Newman's co-authors include S W Clarke, Gary R. Pitcairn, D Pavia, Lars Borgström, William W. Busse, N Talaee, Peter H. Hirst, Folke Morén, Hak‐Kim Chan and K.P. Steed and has published in prestigious journals such as The Lancet, Advanced Drug Delivery Reviews and CHEST Journal.

In The Last Decade

Stephen P. Newman

100 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen P. Newman United Kingdom 45 5.1k 2.4k 636 499 496 101 5.9k
Myrna Dolovich Canada 44 6.8k 1.3× 2.9k 1.2× 546 0.9× 623 1.2× 337 0.7× 146 8.3k
Rajiv Dhand United States 40 4.8k 0.9× 1.9k 0.8× 196 0.3× 379 0.8× 199 0.4× 150 5.9k
Peter R. Byron United States 32 2.9k 0.6× 562 0.2× 945 1.5× 491 1.0× 549 1.1× 99 3.9k
Igor Gonda Australia 37 2.9k 0.6× 767 0.3× 693 1.1× 317 0.6× 322 0.6× 141 4.1k
S W Clarke United Kingdom 41 4.2k 0.8× 2.0k 0.8× 196 0.3× 207 0.4× 100 0.2× 155 5.2k
Anne H. de Boer Netherlands 39 2.9k 0.6× 610 0.3× 1.2k 1.9× 369 0.7× 979 2.0× 101 4.1k
Omar S. Usmani United Kingdom 42 4.4k 0.9× 3.5k 1.4× 188 0.3× 368 0.7× 153 0.3× 194 5.6k
Michael T. Newhouse Canada 46 4.6k 0.9× 2.2k 0.9× 118 0.2× 216 0.4× 93 0.2× 147 5.9k
Michael Hindle United States 40 3.5k 0.7× 649 0.3× 408 0.6× 341 0.7× 661 1.3× 133 4.2k
Warren H. Finlay Canada 49 5.5k 1.1× 767 0.3× 982 1.5× 825 1.7× 997 2.0× 233 7.8k

Countries citing papers authored by Stephen P. Newman

Since Specialization
Citations

This map shows the geographic impact of Stephen P. Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen P. Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen P. Newman more than expected).

Fields of papers citing papers by Stephen P. Newman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen P. Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen P. Newman. The network helps show where Stephen P. Newman may publish in the future.

Co-authorship network of co-authors of Stephen P. Newman

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen P. Newman. A scholar is included among the top collaborators of Stephen P. Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen P. Newman. Stephen P. Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newman, Stephen P.. (2022). Fine Particle Fraction: The Good and the Bad. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(1). 2–10. 25 indexed citations
2.
Newman, Stephen P. & Hak‐Kim Chan. (2020). In vitro-in vivo correlations (IVIVCs) of deposition for drugs given by oral inhalation. Advanced Drug Delivery Reviews. 167. 135–147. 38 indexed citations
3.
Newman, Stephen P.. (2014). Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery. Expert Opinion on Drug Delivery. 11(3). 365–378. 48 indexed citations
4.
Devadason, Sunalene G., Hak‐Kim Chan, Philip J. Kuehl, et al.. (2012). Validation of Radiolabeling of Drug Formulations for Aerosol Deposition Assessment of Orally Inhaled Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25(S1). S–6. 27 indexed citations
5.
Newman, Stephen P., William D. Bennett, Martyn F. Biddiscombe, et al.. (2012). Standardization of Techniques for Using Planar (2D) Imaging for Aerosol Deposition Assessment of Orally Inhaled Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25(S1). S–10. 85 indexed citations
6.
Fleming, John, Dale L. Bailey, Hak‐Kim Chan, et al.. (2012). Standardization of Techniques for Using Single-Photon Emission Computed Tomography (SPECT) for Aerosol Deposition Assessment of Orally Inhaled Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25(S1). S–29. 32 indexed citations
7.
Newman, Stephen P., et al.. (2009). Lung Deposition of Aclidinium Bromide from Genuair®, a Multidose Dry Powder Inhaler. Respiration. 78(3). 322–328. 43 indexed citations
8.
Newman, Stephen P., et al.. (2007). An In Vitro Study to Assess Facial and Ocular Deposition from Respimat ® Soft Mist ™ Inhaler. Journal of Aerosol Medicine. 20(1). 7–12. 10 indexed citations
9.
Newman, Stephen P.. (2005). Principles of Metered-Dose Inhaler Design. Respiratory Care. 50(9). 1177–1190. 172 indexed citations
10.
Hirst, Peter H., et al.. (2002). Lung deposition of budesonide from the novel dry powder inhaler AirmaxTM. Respiratory Medicine. 96(6). 389–396. 25 indexed citations
11.
Hirst, Peter H., Gary R. Pitcairn, Thomas E. Tarara, et al.. (2002). In Vivo Lung Deposition of Hollow Porous Particles from a Pressurized Metered Dose Inhaler. Pharmaceutical Research. 19(3). 258–264. 68 indexed citations
12.
Newman, Stephen P., et al.. (2002). Lung deposition of salbutamol in healthy human subjects from the MAGhaler dry powder inhaler. Respiratory Medicine. 96(12). 1026–1032. 28 indexed citations
13.
Hirst, Peter H., et al.. (2001). A comparison of the lung deposition of budesonide from Easyhaler®, Turbuhaler®and pMDI plus spacer in asthmatic patients. Respiratory Medicine. 95(9). 720–727. 61 indexed citations
14.
Newman, Stephen P.. (2000). Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?. British Journal of Clinical Pharmacology. 49(6). 529–537. 26 indexed citations
15.
Newman, Stephen P., et al.. (1999). Deposition of fenoterol from pressurized metered dose inhalers containing hydrofluoroalkanes☆☆☆. Journal of Allergy and Clinical Immunology. 104(6). s253–s257. 16 indexed citations
16.
Newman, Stephen P., et al.. (1999). Improved targeting of beclomethasone diproprionate (250 μg metered dose inhaler) to the lungs of asthmatics with the Spacehaler™. Respiratory Medicine. 93(6). 424–431. 24 indexed citations
17.
Pitcairn, Gary R. & Stephen P. Newman. (1997). Tissue Attenuation Corrections in Gamma Scintigraphy. Journal of Aerosol Medicine. 10(3). 187–198. 85 indexed citations
18.
19.
Newman, Stephen P. & Anita K. Simonds. (1990). Aerosol therapy in AIDS. Lung. 168(S1). 685–691. 5 indexed citations
20.
Newman, Stephen P., et al.. (1987). In vitro Comparison of DeVilbiss Jet and Ultrasonic Nebulizers. CHEST Journal. 92(6). 991–994. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myrna Dolovich Breakdown of academic impact, for papers by Rajiv Dhand Breakdown of academic impact, for papers by Peter R. Byron Breakdown of academic impact, for papers by Igor Gonda Breakdown of academic impact, for papers by S W Clarke Breakdown of academic impact, for papers by Anne H. de Boer Breakdown of academic impact, for papers by Omar S. Usmani Breakdown of academic impact, for papers by Michael T. Newhouse Breakdown of academic impact, for papers by Michael Hindle Breakdown of academic impact, for papers by Warren H. Finlay
Rankless by CCL
2026